baber/WOPTO huggingface dataset:
Patent WO-2020264086-A1 (WO)
Inventor: ANSARI YOUNES
IPC: H01M4/485
Filed: 2020-06-25
Abstract: Systems and methods for an ultra-high voltage cobalt-free cathode for alkali ion batteries may include an anode, a cathode, and a separator, with the cathode comprising an active material ANi(1-x)MnxSbOy, where x is a number between 0.0 and 1.0, y is an integer, and A comprises one or more of lithium, sodium, and potassium. The anode may include one or more of an alkali metal, silicon, and carbon. In one example, x is a value in the range between 0.05 and 0.9 and y is a value in the range between 1 and 8 where a specific capacity of the active material is greater than 50 milliamp-hours per gram. In another example, x is a value in the range between 0.4 and 0.6 and y is a value in the range between 1 and 8, where a specific capacity of the active material is greater than 70 milliamp-hours per gram.
Patent WO-2021021466-A1 (WO)
Inventor: CHOATE JEREMY
IPC: F16K27/00
Filed: 2020-07-17
Abstract: A quick connect coupling mechanism (200) joins an actuator (102) to a bonnet (104). For example, an actuator housing (202) may be machined or formed to include an opening (218) to enable radial insertion of the bonnet (104) into a slot (204) formed circumferentially about at least a portion of the actuator housing (202). The opening (218) may be secured to block radial movement of the bonnet (104) within the housing (202). A rail system may also be utilized to couple the actuator housing (202) to the bonnet (106). For example, pairs of grooves (610, 612) may be formed in the actuator housing (202) and bonnet (106) to facilitate insertion of rails (626, 628). The rails (626, 628) may block both axial movement of the actuator housing (202) and also block rotational movement.
Patent WO-2021022061-A1 (WO)
Inventor: KOLLURI SIVA
IPC: A61K31/4439
Filed: 2020-07-30
Abstract: Small molecule AhR ligands are disclosed. The ligands can induce the differentiation of Tr1 cells to suppress pathogenic immune responses without inducing nonspecific immune suppression. Methods of treatment of autoimmune diseases using the AhR ligands are also disclosed.
Patent WO-2021026499-A1 (WO)
Inventor: MILGROME OREN
IPC: H01S5/042
Filed: 2020-08-07
Abstract: An apparatus may include an energy rate limiter, an electro-optical transmitter, and an energy monitor. The energy rate limiter limits energy transfer, based on an energy control signal, from a power supply to the energy storage module. The energy storage module is charged based on the energy transfer from the power supply. The electro-optical transmitter includes lasers coupled to local energy storage module. Laser firings of the lasers are based on an electrical potential of the energy storage module and laser enable signals corresponding to the lasers. The energy monitor is coupled to the energy storage module and triggers a safety alarm signal if a voltage provided by the energy storage module violates a safety condition related to a threshold voltage. The energy rate limiter terminates the energy transfer from the power supply to the local energy storage module after the safety condition is violated.
Patent WO-2021035054-A1 (WO)
Inventor: MCCREEDY BRUCE
IPC: A61K39/00
Filed: 2020-08-20
Abstract: La présente invention concerne des procédés et des compositions comprenant des cellules génétiquement modifiées exprimant des récepteurs antigéniques chimériques ou des récepteurs de lymphocytes T exogènes, et des compositions pharmaceutiques associées, pour le traitement du cancer et d'autres troubles et maladies. En outre, l'invention concerne des procédés pour dépléter des lymphocytes chez un sujet ayant besoin d'un traitement avant, en même temps que, ou après l'administration des cellules génétiquement modifiées de l'invention
Patent WO-2021061437-A1 (WO)
Inventor: EVANS DAVID
IPC: A61K38/20
Filed: 2020-09-14
Abstract: L'invention concerne des compositions contenant une molécule d'ARNsi anti-TGF-β et une molécule d'ARNsi anti-PDL1. L'invention concerne également des procédés d'utilisation de ces compositions pour traiter le cancer. La molécule d'ARNsi anti-PDL1 peut contenir une molécule d'ARNsi anti-TGF-βΙ. Une ou les deux molécules peut comprendre un oligonucléotide d'une longueur de 19 paires de bases à 25 paires de bases, et l'une ou les deux peuvent être chimiquement modifiées pour augmenter leur stabilité.
Patent WO-2021071963-A1 (WO)
Title: Mounting structure of cassette with protruded supporter to main body
Inventor: LEE HOIL
IPC: B65H1/26
Filed: 2020-10-07
Abstract: The image forming apparatus may include a main body and a cassette to enter or exit the main body along a first direction to be mounted in or released from the main body, respectively. The cassette may include a supporter extendable in a second direction perpendicular to the first direction to protrude from an exterior of the main body. The main body may include a lever which is movable in the first direction between a supporting position at which the lever supports the main body and a release position at which to allow the cassette to enter or exit the main body along the first direction.
Patent WO-2021086565-A1 (WO)
Title: Weakly basic drug and ionic polymer pharmaceutical formulations and methods of formation and administration thereof
Inventor: WILLIAMS ROBERT
IPC: A61K31/4365
Filed: 2020-10-08
Abstract: The present disclosure relates to pharmaceutical formulations including a weakly basic drug and an ionic polymer in an amorphous solid dispersion, as well as methods of forming such pharmaceutical formulations, and methods of administering such pharmaceutical formulations.
Patent WO-2021076896-A1 (WO)
Inventor: LECOURS ALAIN
IPC: G01F23/26
Filed: 2020-10-16
Abstract: A method of providing electrical energy to a dewar containing a cryogenic liquid including introducing an insulated heat pipe, with a distal end and a proximal end, into a cryogenic dewar comprising an exterior surface. And providing a Seebeck module, with a cold junction and a hot junction. The distal end is in thermodynamic contact with a cryogenic fluid and the proximal is thermodynamically connected to the cold junction. The hot junction is thermodynamically connected to the exterior surface of the dewar, thereby producing an electrical flow in the Seebeck module. A level probe may be calibrated by taking a first capacitance reading with the dewar full, and a second capacitance reading when the cryogenic liquid level is within a calibration gap. The level probe is calibrated by utilizing the first capacitance reading and the second capacitance reading.
Patent WO-2021091688-A1 (WO)
Inventor: MARWAH PANKAJ
IPC: A01N25/00
Filed: 2020-10-20
Abstract: An insecticidal gel formulation including an insecticide active agent, sugar, sorbitol, hydrophilic fumed silica, xanthan gum, and a solvent is disclosed. Further, the insecticidal gel formulation comprises a total amount of hydrophilic fumed silica and xanthan gum of at least 3.6% by weight of the total insecticidal gel formulation.
Patent WO-2021086915-A1 (WO)
Inventor: ZHOU HUI
IPC: E21B43/26
Filed: 2020-10-28
Abstract: Implementations described and claimed herein provide systems and methods for developing resources from an unconventional reservoir. In one implementation, raw reservoir data for the unconventional reservoir is obtained. The raw reservoir data includes geology data, completion data, development data, and production data. The raw reservoir data is transformed to transformed data. The raw reservoir data is transformed to the transformed data based on a transformation from a set of one or more raw variable to a set of one or more transformed variables. The set of one or more transformed variables is statistically uncorrelated. Resource development data is extracted from the transformed data. Performance analytics are generated for the unconventional reservoir using the resource development data. The performance analytics are generated through ensemble machine learning. The unconventional reservoir is developed based on the performance analytics.
Patent WO-2021113429-A1 (WO)
Title: Fuel nozzle with reduced flow tolerance
Inventor: MCCORMACK JIMROY
IPC: F02C7/232
Filed: 2020-12-03
Abstract: A fuel nozzle metering valve that includes a spool having an inlet port and an outlet flow port, and a retainer assembled to one end of the spool. A valve liner houses a portion of the spool. The spool is configured to move back and forth within the valve liner. The metering valve is biased in a closed position in which the outlet flow port is disposed entirely within the valve liner. The valve is opened when the spool slides within the valve liner such that some portion of the outlet flow port extends beyond an end of the valve liner. The retainer has a stepped portion configured to abut an end of the retainer at a fuel flow pressure below the expected maximum fuel flow pressure to be used in the fuel nozzle metering valve.
Patent WO-2021113466-A1 (WO)
Inventor: AQUE RICHARD
IPC: G01M11/02
Filed: 2020-12-03
Abstract: An optic reference signal generator comprising a housing forming an enclosed space with one or more air flow openings. Within the housing is an optic signal generator driver configured to generate an optic signal generator drive signal. An optic signal generator generates an optic signal responsive to the optic signal generator drive signal. A polarity control unit adjusts polarization of the optic signal to create a polarization adjusted optic signal and a modulator bias generator and controller generates a modulation signal. A pattern signal input receives a pattern signal and a modulator receives the polarization adjusted optic signal, the pattern signal, and the modulation signal to generate a modulated output signal.
Patent WO-2021113495-A1 (WO)
Title: Antibacterial carbohydrate vaccine
Inventor: JENNINGS LAURA K
IPC: C07K17/10
Filed: 2020-12-03
Abstract: The present disclosure provides compositions comprising an isolated polysaccharide comprising β-1,4 linked galactosamine and glucosamine monomers, wherein the amino groups of each of the galactosamine and glucosamine are partially substituted with acetate. The disclosure further provides vaccine, methods of use, and methods of producing the isolated polysaccharide.
Patent WO-2021119206-A1 (WO)
Inventor: SCHNABL BERND
IPC: C12Q1/02
Filed: 2020-12-09
Abstract: Methods of diagnosing, monitoring progression or efficacy of therapy, and treating patients with hepatitis or other chronic liver diseases are provided.
Patent WO-2021127034-A1 (WO)
Title: Methods and systems for pathogen mitigation in organic materials
Inventor: PARIS WARREN
IPC: C05F5/00
Filed: 2020-12-16
Abstract: Methods and systems for inhibiting the proliferation of pathogenic microorganisms on organic biomass waste products without the need for pasteurization are described. The methods and systems allow conversion of organic waste into nutrient-rich fertilizers in a safe and efficient manner.
Patent WO-2021138521-A1 (WO)
Title: Device housing with lighting
Inventor: ZIMMERMAN CECILIA
IPC: F21Y103/10
Filed: 2020-12-31
Abstract: The application is directed to a device housing. The device housing includes a first light device, the first light device including a first electrical supply configured to provide an electrical signal to a first light emitting diode (LED), the first LED separated from a first surface of a diffuser film by a space, wherein the diffuser film includes a second surface, opposite the first surface, the second surface configured to contact a first light pipe.
Patent WO-2021141862-A1 (WO)
Inventor: RAULET DAVID H
IPC: A61P37/02
Filed: 2021-01-04
Abstract: L'invention concerne des procédés de modulation de l'activation de la voie du stimulateur des gènes de l'interféron (STING). Des aspects des procédés comprennent la modulation du recrutement de la phosphatidylinositol-4-Kinase bêta (PI4KB) au niveau de Golgi, par exemple, par modulation de l'activité du domaine de liaison acyl-coenzyme A contenant la protéine 3 (ACBD3) et/ou de la protéine de liaison à l'oxystérol (OSBP), pour moduler l'activation de la voie STING. L'invention concerne également des compositions et des kits destinés à être utilisés dans la réalisation des procédés de l'invention. Les procédés et les compositions selon l'invention peuvent être utiles dans différentes utilisations, notamment des utilisations thérapeutiques, telles que des méthodes de traitement du cancer ou d'une maladie inflammatoire.
Patent WO-2021150714-A1 (WO)
Inventor: HAMDI AMINE
IPC: H04L29/06
Filed: 2021-01-21
Abstract: Des systèmes et des procédés permettant de déterminer les sous-systèmes d'un environnement informatique qui sont dans un état d'indépendance mutuelle peuvent comprendre un dispositif informatique qui obtient des informations indiquant un groupe d'actifs d'un sous-système d'un environnement informatique. Pour chaque actif du groupe d'actifs, le dispositif informatique peut identifier un ou plusieurs premiers actifs dont dépend l'actif et un ou plusieurs seconds actifs qui dépendent de l'actif, et déterminer si le(s) premier(s) actif(s) et le(s) second(s) actit(s) appartiennent au groupe d'actifs. Le dispositif informatique peut déterminer que le sous-système est dans un état d'indépendance mutuelle lorsqu'il est déterminé, pour chaque actif du groupe d'actifs, que les premiers et seconds actifs appartiennent au groupe d'actifs. Le dispositif informatique peut mettre à jour un enregistrement de données pour indiquer l'état déterminé du sous-système de l'environnement informatique.
Patent WO-2021150858-A1 (WO)
Title: Minimally-invasive tools and methods for accessing the middle and inner ear through the tympanic membrane
Inventor: DE JUAN EUGENE
IPC: A61F11/00
Filed: 2021-01-22
Abstract: Intra-tympanic injections of therapeutics into the inner ear can be used to treat conditions such as hearing loss. One or more stabilizing devices that define working channels can be temporarily implanted in the tympanic membrane. Purpose-built instruments such as endoscopes, forceps, and injections instruments can be passed through the working channels of the stabilizer devices to access the inner ear where the therapy can be administered. Afterwards, the stabilizing devices can be removed from the tympanic membrane and the tympanic membrane can heal, typically without the need for sutures.
Patent WO-2021150938-A1 (WO)
Title: Secure data processing
Inventor: CHEUNG KAI CHUNG
IPC: H04L9/00
Filed: 2021-01-22
Abstract: A first component determines encrypted data representing an event and encrypted threshold data corresponding to an outlier of the event. The first system may process the data using, for example, one or more composite integers, and may send the result to a second system. This second system may subtract the data to determine of the encrypted data is greater than, less than, or equal to the encrypted threshold. If so, the second system may determine that the encrypted data corresponds to an outlier of the data. The second system may send an indication of this determination to a third system.
Patent WO-2021154763-A1 (WO)
Title: Coronavirus rna vaccines
Inventor: STEWART-JONES GUILLAUME
IPC: A61P11/00
Filed: 2021-01-26
Abstract: The disclosure relates to coronavirus ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines.
Patent WO-2021155188-A1 (WO)
Title: System and method for managing and processing sequenced events in a distributed network
Inventor: SOLODOVNIK ALEKSEY
IPC: G06Q10/06
Filed: 2021-01-29
Abstract: System and method for electronic order management processing may include a sequencer that updates a parent order status maintained at the sequencer based on an order instruction, and generates and multicasts to interface processors of a host server a sequence of events generated based on order instructions and a current order state of the parent order. An event may indicate an order instruction of or related to the parent order, confirmation of completion of a client order or an exchange order of a trade of a portion of the parent order, or an order instruction related to the parent order determined to be in conflict with the current order state. Events may be stored on a queue at a host server according to global sequence numbers assigned at the sequencer, and the interface processors may determine a next action for order processing based on the events on the queue.
Patent WO-2021158590-A1 (WO)
Inventor: WANG LIYA
IPC: C08K3/04
Filed: 2021-02-03
Abstract: L'invention concerne un revêtement contenant du zinc à base de graphène pour empêcher ou ralentir la corrosion de l'acier. Les matériaux à base de graphène sont sélectionnés dans un groupe constitué par le graphène simple couche, le graphène double couche, le graphène multicouche modifiés, une nanoplaquette de graphène, le graphène dopé et une combinaison correspondante. Les matériaux à base de graphène modifié dans des peintures ou des revêtements contenant du zinc agissent comme une barrière pour empêcher ou ralentir la diffusion d'espèces corrosives vers la surface d'acier à protéger. Pour ce faire, le graphène présente un rapport d'aspect élevé et une bonne intégrité structurale, en particulier un manque de défauts sur le plan basal du graphène.
Patent WO-2021188688-A1 (WO)
Title: Farnesoid x receptor agonists for the treatment of disease
Inventor: SONG KENNETH
IPC: A61K31/428
Filed: 2021-03-17
Abstract: Described herein is the use of farnesoid X receptor (FXR) agonists, alone or in combination with additional therapies, in the treatment or prevention of diseases, conditions, or disorders that would benefit from therapy with a FXR agonist.
Patent WO-2021242427-A1 (WO)
Inventor: ZACH NOAM
IPC: H04L27/26
Filed: 2021-04-13
Abstract: Un dispositif de transmission peut réduire un rapport de crête à puissance moyenne (PAPR) en écrêtant des échantillons qui ont une amplitude supérieure à un seuil. Pour une transmission en liaison descendante, le dispositif de transmission peut transmettre un message d'informations de suppression de crête (PSIM) incrémentiel à de multiples équipements utilisateur (UE). Un UE peut procéder aux opérations consistant à : recevoir des informations de commande de liaison descendante (DCI) indiquant des données et un schéma de modulation et de codage (MCS) relatif à l'UE, ainsi qu'au moins un premier PSIM incrémentiel ; décoder ledit au moins un premier PSIM incrémentiel qui peut être appliqué à un MCS inférieur ou égal au MCS relatif à l'UE ; sur la base du MCS relatif à l'UE, déterminer s'il faut décoder un ou plusieurs PSIM incrémentiels ultérieurs ; appliquer des informations de crête provenant des PSIM incrémentiels au canal de données ; et décoder le canal de données sur la base du MCS relatif à l'UE.
Patent WO-2021225890-A1 (WO)
Title: Increasing plasma uniformity in a receptacle
Inventor: GUO TONGTONG
IPC: H01J37/32
Filed: 2021-04-30
Abstract: An apparatus for forming a plasma may include one or more coupling ports to accept and RF current. The apparatus may additionally include a receptacle to accommodate one or more gases, in which the receptacle is oriented along a first axis. The apparatus may additionally include an RF coupling structure, oriented in a plane and substantially surrounding the receptacle, the RF coupling structure can be configured to conduct an RF current to bring about formation of the plasma within the receptacle. The apparatus may further include one or more linkages, coupled to the RF coupling structure, which may permit the plane of the RF coupling structure to pivot about a second axis so as to tilt the plane of the RF coupling structure toward the first axis.
Patent WO-2021231416-A1 (WO)
Title: Reduced subcarrier spacing window
Inventor: MA JUN
IPC: H04L5/00
Filed: 2021-05-11
Abstract: Methods, systems, and devices for wireless communications are described. For example, a user equipment (UE) may transmit, to a base station, an indication of a capability of the UE to switch from monitoring a set of frequency resources according to a first subcarrier spacing (SCS) to monitoring the set of frequency resources according to a second SCS, less than the first SCS. The indication may indicate an amount of time for the UE to switch between SCSs. The UE may receive, from the base station, signaling that indicates a configuration for monitoring the set of frequency resources according to the second SCS (e.g., a configuration for a reduced SCS window). The UE may switch from monitoring the set of frequency resources according to the first SCS to monitoring the set of frequency resources according to the second SCS based on receiving the configuration for monitoring the set of frequency resources.
Patent WO-2022256022-A1 (WO)
Inventor: JOUBERT DES OUCHES PASCAL
IPC: F17C1/02
Filed: 2021-06-07
Abstract: L'invention concerne un contenant qui comprend des première et deuxième coques creuses comprenant respectivement des première et deuxième surfaces internes destinées à recevoir une portion d'une cuve sous pression (PV). La première coque creuse comprend une couche de fibres qui est au moins partiellement imprégnée de résine, et un matériau de dissipation d'énergie qui est sensiblement concentrique avec la première surface interne et disposé entre la première surface interne et la couche de fibres. La deuxième coque creuse comprend une couche de fibres qui est au moins partiellement imprégnée de résine, et un matériau de dissipation d'énergie qui est sensiblement concentrique avec la deuxième surface interne et disposé entre la deuxième surface interne et la deuxième couche de fibres. Les première et deuxième coques creuses peuvent être attachées l'une à l'autre pour définir un volume afin d'enfermer au moins partiellement la PV.
Patent WO-2021252484-A1 (WO)
Title: Compositions for the delivery of therapeutic agents and methods of use and making thereof
Inventor: SLOAT BRIAN R
IPC: A61K9/127
Filed: 2021-06-08
Abstract: Some embodiments pertain to nanoparticle-based compositions and their use in methods for the delivery of therapeutic agents to subjects. In some embodiments, the compositions are stable for prolonged periods of time and provide enhanced bioavailability.
Patent WO-2021252608-A1 (WO)
Title: Disposable arthroscopic suture cutting device
Inventor: MILLER PETER
IPC: A61B17/04
Filed: 2021-06-09
Abstract: A suture cutter that can easily load and retain a tensioned or un-tensioned in place for cutting. The cutter has a handle with a an integral lever and a shaft is coupled to and extending from the handle. A tip has a cutting channel with a cradle for entrapping a suture prior to cutting. A piston in the handle drives a blade pusher to cut the suture in response to movement of the lever. A guide assembly in the body is formed from a pair of members folded together via a living hinge to provide a slot for the head of the piston. The pusher is planar and oriented horizontally within the shaft, while the blade is planar and is oriented vertically at right angles to the pusher. The blade has a tab that is captured by a notch in the pusher to interlock the blade and the pusher.
Patent WO-2021262966-A1 (WO)
Inventor: XUE WEN-MEI
IPC: B01J29/72
Filed: 2021-06-24
Abstract: The present disclosure provides a method for preparing a selective catalytic reduction (SCR) catalyst, the SCR catalyst comprises a metal ion-exchanged zeolite. A method uses an in-situ ion exchange process. A process includes admixing a zeolite in the ammonium (NH 4 
 + ) form with an aqueous mixture comprising water, a transition metal ion source, and, optionally, an acid, to form a slurry containing a metal ion-exchanged zeolite.